<DOC>
	<DOC>NCT01024517</DOC>
	<brief_summary>The purpose of the study is to compare the pharmacokinetics of GLPG0259 as a solid dosage formulation (with and without food)and an oral solution, and to assess its safety and tolerability.</brief_summary>
	<brief_title>GLPG0259 Solid Formulation Bioavailability and Food Effect</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>healthy male, age 1850 years BMI between 1830 kg/mÂ², inclusive. significantly abnormal platelet function or coagulopathy smoking drug or alcohol abuse</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>